Hostname: page-component-f554764f5-nt87m Total loading time: 0 Render date: 2025-04-20T06:36:17.361Z Has data issue: false hasContentIssue false
  • English
  • Français

The next frontier of healthcare-associated infection (HAI) surveillance metrics: Beyond device-associated infections

Published online by Cambridge University Press:  15 January 2024

Sonali D. Advani Open the ORCID record for Sonali D. Advani [Opens in a new window] ,
Kelly Cawcutt Open the ORCID record for Kelly Cawcutt [Opens in a new window] ,
Michael Klompas Open the ORCID record for Michael Klompas [Opens in a new window] ,
Jonas Marschall Open the ORCID record for Jonas Marschall [Opens in a new window] ,
Jennifer Meddings Open the ORCID record for Jennifer Meddings [Opens in a new window]  and
Payal K. Patel
Sonali D. Advani*
Affiliation:
Duke University School of Medicine, Durham, North Carolina, United States
Kelly Cawcutt
Affiliation:
University of Nebraska Medical Center, Omaha, Nebraska, United States
Michael Klompas
Affiliation:
Brigham and Women’s Hospital and Harvard Medical School Harvard Pilgrim Health Care Institute, Boston, Massachusetts, United States
Jonas Marschall
Affiliation:
Bern University Hospital, University of Bern, Bern, Switzerland Washington University School of Medicine, St. Louis, Missouri, United States
Jennifer Meddings
Affiliation:
University of Michigan Medical School, Veterans’ Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan, United States
Payal K. Patel
Affiliation:
Intermountain Healthcare, Salt Lake City, Utah, United States
*
Corresponding author: Sonali D. Advani; Email: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

In recent years, it has become increasingly evident that surveillance metrics for invasive device-associated infections (ie, central-line–associated bloodstream infections, ventilator-associated pneumonias, and catheter-associated urinary tract infections) do not capture all harms; they capture only a subset of healthcare-associated infections (HAIs). Although prevention of device-associated infections remains critical, we need to address the full spectrum of potential harms from device use and non–device-associated infections. These include complications associated with additional devices, such as peripheral venous and arterial catheters, non–device-associated infections such as nonventilator hospital-acquired pneumonia, and noninfectious device complications such as trauma, thrombosis, and acute lung injury. As authors of the device-associated infection sections in the SHEA/IDSA/APIC Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals, we highlight catheter-associated urinary tract infection as an example of the strengths and limitations of the current emphasis on device-associated infection surveillance, suggest performance metrics that present a more comprehensive picture of patient harm, and provide a high-level overview of similar issues with other infection surveillance measures.

Type
Compendium Commentary
Information
Infection Control & Hospital Epidemiology , Volume 45 , Issue 6 , June 2024 , pp. 693 - 697
Check for updates
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Hospital-Acquired Condition Reduction Program (HACRP). Centers for Medicare and Medicaid Services (CMS) website. https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/HAC-Reduction-Program.html. Published July 30, 2018. Accessed December 15, 2023.Google Scholar
Page, B, Klompas, M, Chan, C, et al. Surveillance for healthcare-associated infections: hospital-onset adult sepsis events versus current reportable conditions. Clin Infect Dis 2021;73:1013–1019.CrossRefGoogle ScholarPubMed
Jumani, K, Advani, S, Reich, NG, Gosey, L, Milstone, AM. Risk factors for peripherally inserted central venous catheter complications in children. JAMA Pediatr 2013;167:429–35.CrossRefGoogle ScholarPubMed
Kovacich, A, Tamma, PD, Advani, S, et al. Peripherally inserted central venous catheter complications in children receiving outpatient parenteral antibiotic therapy (OPAT). Infect Control Hosp Epidemiol 2016;37:420–424.10.1017/ice.2015.317CrossRefGoogle ScholarPubMed
Advani, SD, Fakih, MG. The evolution of catheter-associated urinary tract infection (CAUTI): is it time for more inclusive metrics? Infect Control Hosp Epidemiol 2019;40:681–685.CrossRefGoogle ScholarPubMed
Fakih, MG, Gould, CV, Trautner, BW, et al. Beyond infection: device utilization ratio as a performance measure for urinary catheter harm. Infect Control Hosp Epidemiol 2016;37:327–333.CrossRefGoogle ScholarPubMed
Saint, S, Trautner, BW, Fowler, KE, et al. A multicenter study of patient-reported infectious and noninfectious complications associated with indwelling urethral catheters. JAMA Intern Med 2018;178:1078–1085.CrossRefGoogle ScholarPubMed
Schweiger, A, Kuster, SP, Maag, J, et al. Impact of an evidence-based intervention on urinary catheter utilization, associated process indicators, and infectious and noninfectious outcomes. J Hosp Infect 2020;106:364–371.10.1016/j.jhin.2020.07.002CrossRefGoogle Scholar
Klompas, M. Complications of mechanical ventilation—the CDC’s new surveillance paradigm. N Engl J Med 2013;368:1472–1475.CrossRefGoogle ScholarPubMed
Magill, SS, O’Leary, E, Janelle, SJ, et al. Changes in prevalence of healthcare-associated infections in US hospitals. N Engl J Med 2018;379:1732–1744.CrossRefGoogle Scholar
Strassle, PD, Sickbert-Bennett, EE, Klompas, M, et al. Incidence and risk factors of non–device-associated urinary tract infections in an acute-care hospital. Infect Control Hosp Epidemiol 2019;40:1242–1247.10.1017/ice.2019.241CrossRefGoogle Scholar
Calderon, LE, Kavanagh, KT, Rice, MK. Questionable validity of the catheter-associated urinary tract infection metric used for value-based purchasing. Am J Infect Control 2015;43:1050–1052.CrossRefGoogle ScholarPubMed
Waters, TM, Daniels, MJ, Bazzoli, GJ, et al. Effect of Medicare’s nonpayment for hospital-acquired conditions: lessons for future policy. JAMA Intern Med 2015;175:347–354.10.1001/jamainternmed.2014.5486CrossRefGoogle ScholarPubMed
Advani, SD, Gao, CA, Datta, R, et al. Knowledge and practices of physicians and nurses related to urine cultures in catheterized patients: an assessment of adherence to IDSA guidelines. Open Forum Infect Dis 2019;6:ofz305.CrossRefGoogle ScholarPubMed
Bardossy, AC, Williams, T, Jones, K, et al. Culturing practices and the care of the urinary catheter in reducing NHSN-defined catheter-associated urinary tract infections: the tale of two teaching hospitals. Infect Control Hosp Epidemiol 2018;39:1494–1496.CrossRefGoogle ScholarPubMed
Pepe, DE, Maloney, M, Leung, V, et al. An evaluation of metrics for assessing catheter-associated urinary tract infections (CAUTIs): a statewide comparison. Infect Control Hosp Epidemiol 2020;41:481–483.CrossRefGoogle ScholarPubMed
Fakih, MG, Huang, RH, Bufalino, A, et al. The case for a population standardized infection ratio (SIR): a metric that marries the device SIR to the standardized utilization ratio (SUR). Infect Control Hosp Epidemiol 2019;40:979–982.CrossRefGoogle Scholar
Fakih, MG, Greene, MT, Kennedy, EH, et al. Introducing a population-based outcome measure to evaluate the effect of interventions to reduce catheter-associated urinary tract infection. Am J Infect Control 2012;40:359–364.CrossRefGoogle ScholarPubMed
The NHSN standardized utilization ratio (SUR): a guide to the SUR. Centers for Disease Control and Prevention (CDC) website. https://www.cdc.gov/nhsn/pdfs/ps-analysis-resources/nhsn-sur-guide-508.pdf. Accessed December 15, 2023.Google Scholar
Saint, S, Greene, MT, Krein, SL, et al. A program to prevent catheter-associated urinary tract infection in acute care. N Engl J Med 2016;374:2111–2119.CrossRefGoogle ScholarPubMed
Abrantes-Figueiredo, JI, Ross, JW, Banach, DB. Device utilization ratios in infection prevention: process or outcome measure? Curr Infect Dis Rep 2018;20:8.CrossRefGoogle ScholarPubMed
Bates, DW, Goldman, L, Lee, TH. Contaminant blood cultures and resource utilization. The true consequences of false-positive results. JAMA 1991;265:365–369.CrossRefGoogle ScholarPubMed
Whelan, P, Nelson, A, Kim, CJ, et al. Investigating risk factors for urine culture contamination in outpatient clinics: a new avenue for diagnostic stewardship. Antimicrob Steward Healthc Epidemiol 2022;2:e29.CrossRefGoogle ScholarPubMed
Alahmadi, YM, Aldeyab, MA, McElnay, JC, et al. Clinical and economic impact of contaminated blood cultures within the hospital setting. J Hosp Infect 2011;77:233–236.10.1016/j.jhin.2010.09.033CrossRefGoogle ScholarPubMed
Garcia, RA, Spitzer, ED, Beaudry, J, et al. Multidisciplinary team review of best practices for collection and handling of blood cultures to determine effective interventions for increasing the yield of true-positive bacteremias, reducing contamination, and eliminating false-positive central-line–associated bloodstream infections. Am J Infect Control 2015;43:1222–1237.10.1016/j.ajic.2015.06.030CrossRefGoogle ScholarPubMed
Patel, PK, Advani, SD, Kofman, AD, et al. Strategies to prevent catheter-associated urinary tract infections in acute-care hospitals: 2022 update. Infect Control Hosp Epidemiol 2023;44:1209–1231.CrossRefGoogle ScholarPubMed
Fakih, MG, Advani, SD. Striving to reach the optimal measure for catheter-associated urinary tract infection (CAUTI): moving to catheter harm. Clin Infect Dis 2021;72:e424.CrossRefGoogle ScholarPubMed
Klompas, M. Potential strategies to prevent ventilator-associated events. Am J Respir Crit Care Med 2015;192:1420–1430.10.1164/rccm.201506-1161CICrossRefGoogle ScholarPubMed
Klompas, M, Branson, R, Cawcutt, K, et al. Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 update. Infect Control Hosp Epidemiol 2022;43:687–713.10.1017/ice.2022.88CrossRefGoogle ScholarPubMed
Ji, W, McKenna, C, Ochoa, A, et al. Development and assessment of objective surveillance definitions for nonventilator hospital-acquired pneumonia. JAMA Netw Open 2019;2:e1913674.10.1001/jamanetworkopen.2019.13674CrossRefGoogle ScholarPubMed
Jones, BE, Sarvet, AL, Ying, J, et al. Incidence and outcomes of non–ventilator-associated hospital-acquired pneumonia in 284 US hospitals using electronic surveillance criteria. JAMA Netw Open 2023;6:e2314185.CrossRefGoogle ScholarPubMed
Buetti, N, Marschall, J, Drees, M, et al. Strategies to prevent central-line–associated bloodstream infections in acute-care hospitals: 2022 update. Infect Control Hosp Epidemiol 2022;43:553–569.CrossRefGoogle ScholarPubMed
Doern, GV, Carroll, KC, Diekema, DJ, et al. Practical guidance for clinical microbiology laboratories: a comprehensive update on the problem of blood culture contamination and a discussion of methods for addressing the problem. Clin Microbiol Rev 2019;33.Google Scholar
Rhee, C, Dantes, RB, Epstein, L, Klompas, M. Using objective clinical data to track progress on preventing and treating sepsis: CDC’s new ‘adult sepsis event’ surveillance strategy. BMJ Qual Saf 2019;28:305–309.10.1136/bmjqs-2018-008331CrossRefGoogle ScholarPubMed
Rhee, C, Dantes, R, Epstein, L, et al. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009–2014. JAMA 2017;318:1241–1249.CrossRefGoogle ScholarPubMed
Magill, SS, Klompas, M, Balk, R, et al. Developing a new national approach to surveillance for ventilator-associated events: executive summary. Am J Infect Control 2013;41:1096–1099.10.1016/j.ajic.2013.07.001CrossRefGoogle ScholarPubMed